We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

64 hedge funds and large institutions have $9.82M invested in Ampio Pharmaceuticals Inc. in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $72K | Put options by funds: $41K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

10% less funds holding

Funds holding: 71 → 64 (-7)

12% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 17

23% less capital invested

Capital invested by funds: $12.8M → $9.82M (-$2.97M)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

Holders
64
Holders Change
-7
Holders Change %
-9.86%
% of All Funds
1.59%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
15
Reduced
17
Closed
8
Calls
$72K
Puts
$41K
Net Calls
+$31K
Net Calls Change
+$14K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.95M
2
ARTA
A.R.T. Advisors
New York
+$56.4K
3
Wolverine Trading
Wolverine Trading
Illinois
+$29.6K
4
TRCT
Tower Research Capital (TRC)
New York
+$25.5K
5
CCMW
Cypress Capital Management (Wyoming)
Wyoming
+$18.8K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$1.46M
2
Group One Trading
Group One Trading
Illinois
-$71.8K
3
Morgan Stanley
Morgan Stanley
New York
-$71.2K
4
VKH
Virtu KCG Holdings
New York
-$70K
5
BCM
Bridgeway Capital Management
Texas
-$49K
Name Holding Trade Value Shares
Change 		Change in
Stake
NFA
26
Nationwide Fund Advisors
Ohio
$22K – – –
AIG
27
American International Group
New York
$22K +$1.88K +7 +8%
AG
28
Advisor Group
Arizona
$21K – – –
GC
29
Guggenheim Capital
Illinois
$19K – – –
Wells Fargo
30
Wells Fargo
California
$19K – – –
Bank of America
31
Bank of America
North Carolina
$19K +$1.88K +7 +10%
VOYA Investment Management
32
VOYA Investment Management
Georgia
$18K – – –
Goldman Sachs
33
Goldman Sachs
New York
$17K +$18.5K +69 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$16K – – –
JWA
35
JFS Wealth Advisors
Pennsylvania
$16K – – –
OWP
36
Obermeyer Wealth Partners
Colorado
$16K – – –
OC
37
Oppenheimer & Co
New York
$16K – – –
Citadel Advisors
38
Citadel Advisors
Florida
$16K +$17.7K +66 New
FFEC
39
First Financial Equity Corporation
Arizona
$15K +$16.4K +61 New
RJA
40
Raymond James & Associates
Florida
$13K -$538 -2 -4%
Brown Advisory
41
Brown Advisory
Maryland
$13K – – –
JWM
42
Janiczek Wealth Management
Colorado
$13K – – –
LTFS
43
Ladenburg Thalmann Financial Services
Florida
$13K +$2.69K +10 +23%
CC
44
Courier Capital
New York
$11K – – –
PNC Financial Services Group
45
PNC Financial Services Group
Pennsylvania
$11K – – –
Deutsche Bank
46
Deutsche Bank
Germany
$8K -$11.8K -44 -54%
LPL Financial
47
LPL Financial
California
$8K – – –
PAG
48
Private Advisor Group
New Jersey
$8K – – –
WA
49
WealthTrust Axiom
Pennsylvania
$8K – – –
GWM
50
Geneos Wealth Management
Colorado
$7K – – –
1
2
3

AMPE Hedge Fund Activity: Q1 2017 in Review

64 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q1 2017, worth a combined $9.82M — down 23% from $12.8M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of AMPE and 6 opened new positions — a net loss of 2 holders — while 17 trimmed existing stakes and 15 added.

The largest buyer was BlackRock, adding an estimated $2.95M. The largest seller was Susquehanna International Group, cutting an estimated $1.46M.

  • 64 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q1 2017, down from 71 in Q4 2016.
  • Funds reported $9.82M of Ampio Pharmaceuticals Inc. stock for Q1 2017, down 23% quarter-over-quarter.
  • 6 funds opened new Ampio Pharmaceuticals Inc. positions in Q1 2017 and 8 closed out, a net change of -2 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q1 2017 was BlackRock, an estimated $2.95M added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q1 2017 was Susquehanna International Group, an estimated $1.46M sold.

Based on aggregated 13F filings for Q1 2017.